SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Chemiesynth (Vapi) Ltd

BSE: 539230 NSE: ISIN: INE829R01018
  |   Sector:  Chemicals & Fertilizers   |   Industry:  Chemicals

Snapshot

Q.1 Which industry/sub-sector does Chemiesynth (Vapi) Ltd belong to?
Chemiesynth (Vapi) Ltd belongs to the Chemicals & Fertilizers sector, operating specifically within the Chemicals segment.
Q.2 Is Chemiesynth (Vapi) Ltd a good quality company?
Chemiesynth (Vapi) Ltd is a quality company, based on a 10 year financial track record.
Q.3 Is Chemiesynth (Vapi) Ltd undervalued or overvalued?
Chemiesynth (Vapi) Ltd appears Fair, as its key valuation ratios are in line with their past averages.
Q.4 Is Chemiesynth (Vapi) Ltd a good buy now?
Chemiesynth (Vapi) Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Chemiesynth (Vapi) Ltd?
Chemiesynth (Vapi) Ltd revenue growth is 15% for FY-2025 , which is above its 5 year CAGR of 5.4% , indicating faster growth.
Q.2 Gross Profit margin of Chemiesynth (Vapi) Ltd?
Chemiesynth (Vapi) Ltd Gross profit margin which is the profit after deduction of direct costs, is 7.4% for FY-2025 , which is below its 5 year median of 9.5% , indicating decreasing margins.
Q.3 Operating Profit Margin of Chemiesynth (Vapi) Ltd?
Chemiesynth (Vapi) Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 11.7% for FY-2025 , which is below its 5 year median of 12.27% indicating decreasing margins.
Q.4 Net Profit Margin of Chemiesynth (Vapi) Ltd?
Chemiesynth (Vapi) Ltd Net Profit Margin is -0.56% for FY-2025 , is below with its 5 year median of 2.65%, indicating decreasing margins.
Current Level Historic Median
Gross Profit Margin 7.4 9.5
Operating Profit Margin 11.7 12.27
Net Profit Margin -0.56 2.65
Q.5 Return on Asset of Chemiesynth (Vapi) Ltd?
Chemiesynth (Vapi) Ltd Return on Asset is -0.33%, which is below its 5 year historical median of 1.83%, indicating deteriorated asset utilization efficiency.
Q.6 Return on Equity (ROE) of Chemiesynth (Vapi) Ltd?
Chemiesynth (Vapi) Ltd Return on equity is -0.95% for FY-2025 , which is below its historical median of 4.85%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Chemiesynth (Vapi) Ltd?
Chemiesynth (Vapi) Ltd Return on capital employed is 3.1% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Chemiesynth (Vapi) Ltd?
Chemiesynth (Vapi) Ltd Cash conversion cycle is 61 days, above its historical median of 25 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.59 0.69
ROE -0.95 4.85
ROCE 3.1 5.85
Cash Conversion Cycle 61 days 25 days
Q.9 Debt to Equity ratio of Chemiesynth (Vapi) Ltd?
Chemiesynth (Vapi) Ltd Debt-to-Equity ratio is 1.37 , which is above with the industry average of 0.13 , indicating higher debt levels in the industry.
Q.10 Debt to cash flow from operations of Chemiesynth (Vapi) Ltd?
Chemiesynth (Vapi) Ltd Debt to cash flow from operations is 5.67 , which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Chemiesynth (Vapi) Ltd?
Promoters hold 62.35% of the Chemiesynth (Vapi) Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Chemiesynth (Vapi) Ltd vs industry peers?
Chemiesynth (Vapi) Ltd revenue CAGR is 5.35% , compared to the industry median CAGR of 7.58% , indicating slower growth and losing its market share.
Profit Metrics
Current Level Industry Median
Revenue 18.9 202
Gross Profit 1.4 23.6
Operating Profit 2.2 24
Net Profit -0.1 12
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.59 0.93
ROE -0.95 10.17
ROCE 3.1 12.96
Cash Conversion Cycle (days) 61.08 62

Valuation & price assessment

Q.1 Stock return of Chemiesynth (Vapi) Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of 40.1% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price - - 40.1% 61.1%
Q.3 Valuation ratios of Chemiesynth (Vapi) Ltd vs historical?
The current P/E is lower that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings - 1.76 41.15
Price to Book 1.73 0.57 2.38
Price to Sales 0.72 0.31 1.93
EV to EBITDA 28.04 8.36 13.71

Check more companies

1. Godrej Industries
2. Navin Fluorine Intl
3. Deepak Nitrite
4. Atul
5. Tata Chemicals
6. Aarti Inds
7. BASF India
8. Deepak Fert & Petro
9. Aether Industries
10. Anupam Rasayan India
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×